McKesson Corporation (MCK) EPS Estimated At $2.89

January 23, 2018 - By Dolores Ford

 McKesson Corporation (MCK) EPS Estimated At $2.89
Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.07, from 0.95 in 2017Q2. It dropped, as 65 investors sold McKesson Corporation shares while 296 reduced holdings. 72 funds opened positions while 246 raised stakes. 180.04 million shares or 2.23% more from 176.11 million shares in 2017Q2 were reported.
First Manhattan Communications has invested 0% in McKesson Corporation (NYSE:MCK). Tci Wealth Advisors Incorporated invested in 1,525 shares. City Tru Communication Fl invested 0.89% in McKesson Corporation (NYSE:MCK). Pitcairn Commerce has 4,344 shares for 0.08% of their portfolio. Moreover, California Public Employees Retirement has 0.12% invested in McKesson Corporation (NYSE:MCK) for 510,694 shares. Kbc Grp Nv stated it has 0.28% of its portfolio in McKesson Corporation (NYSE:MCK). Hancock Hldg accumulated 12,583 shares. Envestnet Asset Management invested in 34,139 shares or 0.01% of the stock. Optimum owns 2,544 shares for 0.13% of their portfolio. Highstreet Asset holds 9,703 shares or 0.14% of its portfolio. Moreover, Morgan Stanley has 0.04% invested in McKesson Corporation (NYSE:MCK) for 961,074 shares. Sivik Global Health Lc stated it has 25,000 shares. Livforsakringsbolaget Skandia Omsesidigt owns 10,143 shares or 0.14% of their US portfolio. Alpine Woods Limited Liability Corp has 0.46% invested in McKesson Corporation (NYSE:MCK). Clearbridge Ltd Liability holds 472 shares or 0% of its portfolio.

Since August 21, 2017, it had 0 buys, and 6 insider sales for $121.83 million activity. 900 shares were sold by Lampert Erin M, worth $140,089 on Thursday, September 7. Shares for $157,500 were sold by JACOBS M CHRISTINE on Monday, August 21.

Analysts expect McKesson Corporation (NYSE:MCK) to report $2.89 EPS on January, 24.They anticipate $0.14 EPS change or 4.62 % from last quarter’s $3.03 EPS. MCK’s profit would be $602.50 million giving it 14.96 P/E if the $2.89 EPS is correct. After having $3.28 EPS previously, McKesson Corporation’s analysts see -11.89 % EPS growth. The stock increased 1.53% or $2.6 during the last trading session, reaching $172.96. About 1.56M shares traded. McKesson Corporation (NYSE:MCK) has declined 15.45% since January 23, 2017 and is downtrending. It has underperformed by 32.15% the S&P500.

McKesson Corporation (NYSE:MCK) Ratings Coverage

Among 22 analysts covering McKesson Corporation (NYSE:MCK), 11 have Buy rating, 1 Sell and 10 Hold. Therefore 50% are positive. McKesson Corporation has $275 highest and $130.0 lowest target. $190.45’s average target is 10.11% above currents $172.96 stock price. McKesson Corporation had 74 analyst reports since July 31, 2015 according to SRatingsIntel. As per Tuesday, May 23, the company rating was upgraded by JP Morgan. The rating was maintained by Mizuho on Monday, September 21 with “Buy”. Deutsche Bank downgraded the stock to “Hold” rating in Friday, October 28 report. On Tuesday, October 24 the stock rating was maintained by Mizuho with “Hold”. Credit Suisse downgraded the stock to “Underperform” rating in Wednesday, November 23 report. The stock of McKesson Corporation (NYSE:MCK) has “Neutral” rating given on Tuesday, January 3 by Mizuho. The stock of McKesson Corporation (NYSE:MCK) earned “Buy” rating by Goldman Sachs on Wednesday, November 4. Raymond James downgraded the stock to “Mkt Perform” rating in Tuesday, January 12 report. The stock has “Buy” rating by S&P Research on Friday, July 31. As per Wednesday, November 1, the company rating was maintained by Needham.

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. The company has market cap of $36.06 billion. The firm operates in two divisions, McKesson Distribution Solutions and McKesson Technology Solutions. It has a 8.19 P/E ratio. The McKesson Distribution Solutions segment distributes branded and generic pharmaceutical drugs, and other healthcare-related products; and provides practice management, technology, clinical support, and business solutions to community oncology and other specialty practices.

More notable recent McKesson Corporation (NYSE:MCK) news were published by: which released: “McKesson: Is This Pharmaceutical Distributor A Buy?” on December 31, 2017, also with their article: “McKesson Ventures Donates $10000 to Alzheimer’s Association” published on January 16, 2018, published: “5 Reasons Why McKesson Deserves a Place in Your Portfolio” on January 17, 2018. More interesting news about McKesson Corporation (NYSE:MCK) were released by: and their article: “Andy Beshear sues national opioid distributor, saying it flooded Kentucky with …” published on January 22, 2018 as well as‘s news article titled: “McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for …” with publication date: January 04, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.